Ann Calby Miller's Net Worth
$703 Thousand
Who is Ann Calby Miller?
Ann Calby Miller does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include INOVIO PHARMACEUTICALS, INC., PUMA BIOTECHNOLOGY, INC., and Allena Pharmaceuticals, Inc..
SEC CIK
Ann Calby Miller's CIK is 0001771423
Past Insider Trading and Trends
2020 was Ann Calby Miller's most active year for acquiring shares with 6 total transactions. Ann Calby Miller's most active month to acquire stocks was the month of April. 2021 was Ann Calby Miller's most active year for disposing of shares, totalling 3 transactions. Ann Calby Miller's most active month to dispose stocks was the month of April. 2019 saw Ann Calby Miller paying a total of $0.00 for 178,640 shares, this is the most they've acquired in one year. In 2021 Ann Calby Miller cashed out on 25,848 shares for a total of $147,156.26, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INOVIO PHARMACEUTICALS, INC. (INO) Snapshot price: $5.27
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +39.97% | 19K |
—
|
—
| 66.53K |
May 15 - May 16
| |||
Form 4
| +60.95% | 18K |
—
|
—
| 47.53K |
May 13 - May 16
| |||
Form 4
| +16.92% | 4.27K |
—
|
—
| 29.53K |
Mar 21
| |||
Form 4
| +52.53% | 8.7K |
—
|
—
| 25.26K |
May 13 - May 14
| |||
Form 4
| +34.78% | 4.27K |
—
|
—
| 16.56K |
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
| +187.48% | 8.01K |
—
|
—
| 12.29K |
May 8
| |||
Form 4
|
∞
| 4.27K |
—
|
—
| 4.27K |
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PUMA BIOTECHNOLOGY, INC. (PBYI) Snapshot price: $5.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +216.39% | 27.86K |
—
|
—
| 40.73K |
Jun 15
| |||
Form 4
| -50.00% | -12.87K |
$11.43 | -$147,156.26 | 12.87K |
Jun 10
| |||
Form 4
|
∞
| 25.75K |
—
|
—
| 25.75K |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Allena Pharmaceuticals, Inc. (ALNAQ) Snapshot price: $0.0065
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |